Author

Vipul Bhatia

University of California, Los AngelesORCID 0000-0002-4091-8866Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:proteomics· 2 Approach:statistical model· 2 Approach:biophysical modeling· 1

Frequent Co-Authors

John K. LeeiD· 4 shared Kai SongiD· 2 shared Thomas G. GraeberiD· 2 shared Truman Chong· 2 shared Annabelle TsaoiD· 1 shared Arthur J. Y. HuangiD· 1 shared Aude G. ChapuisiD· 1 shared Behnam NabetiD· 1 shared

Activity by Year

2024-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

John K. LeeORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Armoring STEAP1 CAR T cells with IL-18 potentiates antitumor activity in Ewing sarcoma

Vipul Bhatia, Annabelle Tsao, Truman Chong, Peter P. Challita, Keke Liang, Erolcan Sayar, Jiaoti Huang, Elizabeth R. Lawlor, Michael C. Haffner, Behnam Nabet, John K. Lee

This study shows that IL-18-armored STEAP1 CAR T cells effectively treat Ewing sarcoma with reduced dose and improved efficacy.

bioRxiv · Dec 11, 2025 · PreprintCancer Biology

Collagen-binding IL-12 expressing STEAP1 CAR-T cells reduce toxicity and eradicate mouse prostate cancer in combination with checkpoint inhibitors

Koichi Sasaki, Vipul Bhatia, Yuta Asano, Jakob Bakhtiari, Pooja Kaur, Chuyi Wang, Takumi Matsuo, Olivier Dubois, Po-Chuan Chiu, Donny Gun, Charanjit Singh, Ioanna Panagi, Laurine Noblecourt, Maria Nikolaidi, Truman Chong, , Jun Ishihara

Nature Biomedical Engineering · Oct 23, 2025Peer-reviewedBioengineering

Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer

Shan Li, Kai Song, Huiyun Sun, Yong Tao, Arthur J. Y. Huang, Vipul Bhatia, Brian P. Hanratty, Radhika A. Patel, Henry W. Long, Colm M. Morrissey, Michael C. Haffner, Peter S. Nelson, Thomas G. Graeber, John K. Lee

This study reprograms AR-active prostate cancer to NEPC using ASCL1 and NeuroD1, revealing their role in silencing AR and altering chromatin structure.

bioRxiv · Feb 12, 2025 · PreprintCancer Biology

PGC-1a drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity

Grigor Varuzhanyan, Chia‐Chun Chen, Jack Freeland, He Tian, Wendy Tran, Kai Song, Liang Wang, Donghui Cheng, Shili Xu, Gabriella DiBernardo, Favour N. Esedebe, Vipul Bhatia, Mingqi Han, Evan R. Abt, Jung Wook Park, , Owen N. Witte

Proceedings of the National Academy of Sciences · Nov 26, 2024Peer-reviewedCancer Biology